Korro Bio, Inc.·4

Feb 5, 4:14 PM ET

Olugemo Olukemi 4

4 · Korro Bio, Inc. · Filed Feb 5, 2025

Insider Transaction Report

Form 4
Period: 2025-02-03
Olugemo Olukemi
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-03+42,00042,000 total
    Exercise: $33.50Exp: 2035-02-02Common Stock (42,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest in 48 equal monthly installments commencing from February 3, 2025, subject to the Reporting Person's continued service on each such vesting date.

Documents

2 files